The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Biological activities of sinularin: A literature-based review
Corresponding Author(s) : Ryszard Amarowicz
r.amarowicz@pan.olsztyn.pl
Cellular and Molecular Biology,
Vol. 66 No. 4: Medicinal plants and natural products
Abstract
Sinularin ((9E)-13-hydroxy-4,9,13-trimethyl-17-methylidene-5,15-dioxatricyclo[12.3.1.0(4,6)] octadec-9-en-16-one) is the soft coral-derived hopeful biologically active lead compound. In this review sinularin biological activities are summarized. For that, an up-to-date (from 1980 to Mar 2020) search was made in the PubMed, Science Direct, Web of Science, Scopus, The American Chemical Society, Clinicaltrials.gov, and Google Scholar databases. Data available suggest that sinularin has interesting anti-inflammatory, anticancer, anti-fouling and analgesic potential. The inducible nitric oxide synthase (iNOS), cyclooxigenase (COX)-2, tumor growth factor beta 1 (TGF-β1) are the most efficient enzymes for interacting with sinularin due to its anti-inflammatory activity, while phosphoinositol 3-kinase (PI3K), Akt and mechanistic target of rapamycin (mTOR) for its anticancer effect. In conclusion, sinularin seems to be a promissory lead compound in the treatment of inflammation, cancer and neurological disorders.
Keywords
Marine drugs
Sinularin
Inflammation
Cancer.
Islam, M. T., Hossain, R., Hassan, S. M. H., Salehi, B., Martins, N., Sharifi-Rad, J., & Amarowicz, R. (2020). Biological activities of sinularin: A literature-based review. Cellular and Molecular Biology, 66(4), 33–36. https://doi.org/10.14715/cmb/2020.66.4.6
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX